1. Home
  2. TCBI vs MMED Comparison

TCBI vs MMED Comparison

Compare TCBI & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Texas Capital Bancshares Inc.

TCBI

Texas Capital Bancshares Inc.

HOLD

Current Price

$98.99

Market Cap

4.5B

Sector

Finance

ML Signal

HOLD

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$18.45

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TCBI
MMED
Founded
1996
1983
Country
United States
United States
Employees
1785
2800
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.3B
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
TCBI
MMED
Price
$98.99
$18.45
Analyst Decision
Hold
Strong Buy
Analyst Count
13
10
Target Price
$100.92
$22.56
AVG Volume (30 Days)
513.7K
1.1M
Earning Date
04-23-2026
06-03-2026
Dividend Yield
0.81%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.76
$15.99
Revenue Next Year
$7.47
$10.00
P/E Ratio
$15.46
N/A
Revenue Growth
N/A
N/A
52 Week Low
$75.41
$10.65
52 Week High
$108.92
$18.67

Technical Indicators

Market Signals
Indicator
TCBI
MMED
Relative Strength Index (RSI) 39.83 72.69
Support Level $97.23 $14.70
Resistance Level $106.96 N/A
Average True Range (ATR) 2.30 0.95
MACD -0.75 0.16
Stochastic Oscillator 11.28 93.20

Price Performance

Historical Comparison
TCBI
MMED

About TCBI Texas Capital Bancshares Inc.

Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.

Share on Social Networks: